Infectious Disease Clinics of North America
Volume 24, Issue 3 , Pages 619-638, September 2010

Severe Acute Respiratory Syndrome and Coronavirus

  • David S.C. Hui, MD(UNSW), FRACP, FRCP

      Affiliations

    • Division of Respiratory Medicine, Stanley Ho Center for Emerging Infectious Diseases, Prince of Wales Hospital, The Chinese University of Hong Kong, Prince of Wales Hospital, 30-32 Ngan Shing Street, Shatin, New Territories, Hong Kong, China
    • Corresponding Author InformationCorresponding author.
  • ,
  • Paul K.S. Chan, MD, FRCPath

      Affiliations

    • Department of Microbiology, The Chinese University of Hong Kong, Prince of Wales Hospital, 32 Ngan Shing Street, Shatin, New Territories, Hong Kong, China

Severe acute respiratory syndrome (SARS) is a highly infectious disease with a significant morbidity and mortality. Respiratory failure is the major complication, and patients may progress to acute respiratory distress syndrome. Health care workers are particularly vulnerable to SARS. SARS has the potential of being converted from droplet to airborne transmission. There is currently no proven effective treatment of SARS, so early recognition, isolation, and stringent infection control are the key to controlling this highly contagious disease. Horseshoe bats are implicated in the emergence of novel coronavirus infection in humans. Further studies are needed to examine host genetic markers that may predict clinical outcome.

Keywords: SARS, Clinical features, Pathogenesis, Treatment, Outcome

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0891-5520(10)00036-X

doi:10.1016/j.idc.2010.04.009

Infectious Disease Clinics of North America
Volume 24, Issue 3 , Pages 619-638, September 2010